Receiver operating characteristic (ROC) curve analysiswas performed and the area under the ROC curve (AUC)was calculated to examine whether ANRIL expressioncan be used as biomarker for identifying T2DM patientswith CAD. This evidence concerns the gene CDKN2B-AS1 and type 2 diabetes mellitus.